Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

被引：0
|
作者：
Igawa, S. [1 ]
Fukui, T. [1 ]
Shirasawa, M. [1 ]
Ozawa, T. [1 ]
Sone, H. [1 ]
Kusuhara, S. [1 ]
Nishinarita, N. [1 ]
Hiyoshi, Y. [1 ]
Kubota, M. [1 ]
Mitsufuji, H. [2 ]
Sasaki, J. [3 ]
Katagiri, M. [4 ]
Naoki, K. [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Small Cell Lung Cancer; Elderly patients; Performance status; Amrubicin;
D O I：
10.1016/j.jtho.2018.08.837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.12-02
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [31] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    H Okamoto
    K Watanabe
    H Kunikane
    A Yokoyama
    S Kudoh
    T Asakawa
    T Shibata
    H Kunitoh
    T Tamura
    N Saijo
    British Journal of Cancer, 2007, 97 : 162 - 169
  • [32] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    Okamoto, H.
    Watanabe, K.
    Kunikane, H.
    Yokoyama, A.
    Kudoh, S.
    Asakawa, T.
    Shibata, T.
    Kunitoh, H.
    Tamura, T.
    Saijo, N.
    BRITISH JOURNAL OF CANCER, 2007, 97 (02) : 162 - 169
  • [33] PHASE II STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED NON-SMALL CELL LUNG CANCER
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Yoshioka, Hiroshige
    Kitagawa, Chiyoe
    Saka, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S875 - S875
  • [34] Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer
    Oshita, Fumihiro
    Sugiura, Makiko
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Yamada, Kouzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 345 - 350
  • [35] Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naIve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901
    Morikawa, Naoto
    Inoue, Akira
    Sugawara, Shunichi
    Maemondo, Makoto
    Harada, Toshiyuki
    Harada, Masao
    Fujita, Yuka
    Katoh, Terufumi
    Yokouchi, Hiroshi
    Watanabe, Hiroshi
    Usui, Kazuhiro
    Suzuki, Toshiro
    Sakakibara-Konishi, Jun
    Nagai, Hiroki
    Kanbe, Mariko
    Nukiwa, Toshihiro
    LUNG CANCER, 2017, 111 : 38 - 42
  • [36] Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium
    Spigel, David R.
    Hainsworth, John D.
    Shipley, Dianna L.
    Mekhail, Tarek M.
    Zubkus, John D.
    Waterhouse, David M.
    Daniel, Davey B.
    Burris, Howard A., III
    Greco, F. Anthony
    LUNG CANCER, 2018, 117 : 38 - 43
  • [37] Dose escalation study of amrubicin in combination with fixed-dose irinotecan in patients with extensive small-cell lung cancer
    Oshita, Fumihiro
    Saito, Haruhiro
    Yamada, Kouzo
    ONCOLOGY, 2008, 74 (1-2) : 7 - 11
  • [38] Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer
    Ogawara, Daiki
    Nakamura, Yoichi
    Fukuda, Minoru
    Nakatomi, Katsumi
    Yamaguchi, Hiroyuki
    Motoshima, Kohei
    Mizoguchi, Kosuke
    Nakano, Hirofumi
    Takemoto, Shinnosuke
    Gyotoku, Hiroshi
    Nagashima, Seiji
    Kohno, Shigeru
    CHEMOTHERAPY, 2014, 60 (03) : 180 - 184
  • [39] A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer
    Chang Dong Yeo
    Sang Haak Lee
    Ju Sang Kim
    Seung Joon Kim
    Seok Chan Kim
    Young Kyoon Kim
    Hyeon Hui Kang
    Hyung Kyu Yoon
    Jeong Sup Song
    Hwa Sik Moon
    Jin Woo Kim
    Kwan Hyoung Kim
    Byoung Yong Shim
    Chi Hong Kim
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 809 - 814
  • [40] A MULTICENTER PHASE II STUDY OF BELOTECAN, A NEW CAMPTOTHECIN ANALOGUE, IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED, EXTENSIVE-STAGE SMALL CELL LUNG CANCER
    Yeo, Chang Dong
    Choi, Si Young
    Lee, Sang Haak
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1230 - S1230
12345